Register to receive a free European Market Report Suite for Anesthesia, Respiratory and Sleep Management report synopsis and brochure
According to a new series of reports on the European market for anesthesia, respiratory and sleep management by iData Research, the rise in chronic obstructive pulmonary disease (COPD) in Europe has resulted in a greater number of new patients requiring respiratory treatment and assistance, serving to increase demand for devices in the oxygen therapy market. The market for oxygen therapy is broken into two types of devices: concentrators and transfilling devices, with concentrators further segmented into categories for ambulatory and stationary devices.
Among Western European countries, France has the largest number of patients on long-term oxygen therapy and the extensive use of oxygen concentrators is encouraged by some of the highest reimbursement rates in Europe. In contrast, the market for alternative oxygen therapy devices in Italy is well below what population levels or the number of COPD patients would suggest. This is largely due to the fact that the reimbursement and regulatory system in Italy is heavily weighted toward the use of liquid oxygen. France and Germany are the largest markets in Europe for oxygen concentrators.
“The number of patients requiring medical oxygen is expected to increase between 4% and 6% per year as the population ages and as incidence rates for chronic respiratory conditions increase,” explains Dr. Kamran Zamanian, CEO of iData. “Growth in unit sales is primarily driven by increasing acceptance and adaptation of ambulatory concentrators within the ambulatory oxygen marketplace.”
One of the primary drivers for sales in oxygen therapy devices is the move within the ambulatory market from traditional cylinder-based methods of oxygen delivery to ambulatory concentrating technology. While the ambulatory concentrators will always be a more expensive up-front cost to providers, experience with the new systems is beginning to demonstrate long-term cost effectiveness. Device sales have grown rapidly over the last several years as household users have begun to switch from delivered oxygen to alternative devices. However, this rate of adoption will diminish with time and replacement devices will begin to account for a significant share of the market.
Invacare is the market leader for oxygen therapy in Europe. They have a strong presence in both the stationary and ambulatory concentrator markets, as well as the market for transfilling devices. Invacare sells their stationary concentrators under the Perfect O2® and Platinum® names. Philips Respironics is the second leading competitor in the European oxygen therapy market. As part of the Philips family of companies, Philips Respironics has a large distribution network and significant marketing resources. The company has made significant gains in the concentrator market since the introduction of the EverGo® ambulatory oxygen concentrator in 2008. DeVilbiss is the third leading competitor in the overall oxygen therapy market in Europe producing one of Europe’s leading transfilling devices, the DeVilbiss iFill® transfiller. Additional competitors in the oxygen therapy market include AirSep, Inogen, RanaCareGroup, SeQual, Siare and VitalAire among others.
For Further Information
More on the oxygen therapy market in Europe can be found in a series of reports published by iData Research entitled the European Market Report Suite for Anesthesia, Respiratory and Sleep Management. The suite covers reports on the following markets: Anesthesia Delivery Units, Anesthesia Disposables, Ventilators, Nebulizers, Respiratory Disposables, Oxygen Therapy, Sleep Apnea Devices and Interfaces, and Sleep Diagnostic Devices.
The iData report series on anesthesia, respiratory and sleep management covers the U.S. and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, the United Kingdom and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about anesthesia, respiratory and sleep management market data or procedure data, register online or email us at [email protected] for a European Market Report Suite for Anesthesia, Respiratory and Sleep Management brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.